£2.5M
The financing round includes contributions from Deepbridge Capital, Scottish Enterprise, SIS Ventures, Thairm Bio, and the University of Strathclyde to support clinical trials and commercial expansion.
MD
Microplate Dx
Microplate Dx develops a rapid diagnostic platform to identify effective antibiotic treatments.
Glasgow, UK—Founded 2022
£2.5MTotal raised
Microplate Dx develops a rapid diagnostic platform designed to detect bacterial infections and identify effective antibiotic treatments within minutes. The University of Strathclyde spinout focuses on tackling antimicrobial resistance starting with urinary tract infections.
Categories
Founders
SH
Stuart Hannah
CEO
DC
Damion Corrigan
CTO
PH
Paul Hoskisson
CSO
PM
Poonam Malik
Chair